<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Skin Revive Aesthetics]]></title><description><![CDATA[Best medical aesthetics in Lancaster - offering medical grade service in a warm and friendly environment. ]]></description><link>https://www.skinreviveaesthetics.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Thu, 15 Oct 2026 01:09:13 GMT</lastBuildDate><atom:link href="https://www.skinreviveaesthetics.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Ozempic Face and Mounjaro Face: What Happens to Your Skin and How to Treat It]]></title><description><![CDATA[Ozempic face and Mounjaro face — the facial hollowing, skin laxity, and textural changes that follow GLP-1 weight loss — are not permanent. This clinical guide explains what causes them, what the treatment options are, and how the Restore Protocol at Skin Revive Aesthetics in Lancaster addresses all aspects with a structured 12-week programme.]]></description><link>https://www.skinreviveaesthetics.com/post/ozempic-face-and-mounjaro-face-what-happens-to-your-skin-and-how-to-treat-it</link><guid isPermaLink="false">6acf56b1ef18c7d57a0557dc</guid><pubDate>Wed, 14 Oct 2026 10:17:21 GMT</pubDate><dc:creator>Andrew Wilkinson</dc:creator></item><item><title><![CDATA[Frequently Asked Questions: Post-GLP-1 Skin, Treatments and the Restore Protocol]]></title><description><![CDATA[Comprehensive answers to the questions patients most commonly ask about Ozempic face, Mounjaro face, post-GLP-1 skin changes, RF microneedling, HIFU, polynucleotides, and the Restore Protocol at Skin Revive Aesthetics in Lancaster. Written by Liona Harris, HCPC-registered physiotherapist.]]></description><link>https://www.skinreviveaesthetics.com/post/frequently-asked-questions-post-glp-1-skin-treatments-and-the-restore-protocol</link><guid isPermaLink="false">6acf56b1ef18c7d57a0557dd</guid><pubDate>Wed, 14 Oct 2026 10:17:21 GMT</pubDate><dc:creator>Andrew Wilkinson</dc:creator></item></channel></rss>